Rezultati pretraživanja
  1. prije 21 sat
  2. prije 22 sata

    Announces Board of Directors Appointment | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology via

  3. 4. velj
  4. 28. sij
  5. 24. sij

    Joe Rogan Explains Why Athletes Should Be Worried About Sleep Apnea Via "According to the CDC, 1 in 3 Americans don't get enough rest, and one of the leading causes is "

  6. 24. sij

    is developing a pipeline of new drug products based on our broad patent portfolios for 2 drug platforms: , including (D9-), and the ampakines...

  7. 15. lis 2019.
  8. 11. ruj 2019.
  9. 11. ruj 2019.

    Panel Discussion: The ’s Perspective on the Field.” Pharmaceuticals Inc. Executives Participating in the 2nd Annual International Cannabinoid Derived Pharmaceuticals Summit

  10. 9. ruj 2019.

    Inc. Executives Participating in the 2nd Annual International Derived Pharmaceuticals Summit “RespireRx is at the forefront of developing for the treatment of neurologically based diseases because w…

  11. 21. ožu 2019.

    Impression Healthcare teams up with Cannvalate in ‘first of its kind’ trial and distribution deal.

  12. 19. velj 2019.

    (Omaha) Pharmaceuticals Inc. and Impression Healthcare Limited Announce Agreement to Explore Commercialization of Dronabinol for the Treatment of Obstructive Sleep Apnea () in Australia, New Zealand and Southeast Asia : Glen Rock, ..

  13. 14. velj 2019.

    Obstructive Sleep Apnoea market = US$5.5B in 2017 executed a memorandum of understanding + Agreement with Pharmaceuticals to negotiate the terms for to a -venture with for

  14. 10. pro 2018.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.